Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 3:54 a.m.

    📋 TURNING POINT THERAPEUTICS, INC. (TPTX) - Business Combination

    Filing Date: 2022-06-03

    Accepted: 2022-06-03 09:00:32

    Event Type: Business Combination

    Event Details:

    Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) Announces Business Combination Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) has entered into a strategic transaction. Transaction Details:
    • Transaction: Bristol Myers Squibb to acquire Turning Point Therapeutics
    • Deal Value: $4.1 million

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY))
    • CIK: 0001595893
    • Ticker Symbol: TPTX
    • Period End Date: 2022-06-02
    • Document Type: 8-K

Search

News categories